Formulary
No Formulary Selected

close

 

Select a medication above to begin.

Bifidobacterium lactis

Bifidobacterium animalis subsp. lactis

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • allergic rhinitis [Insufficient Evidence]
  • aphthous ulcer (canker sores) [Insufficient Evidence]
  • atopic dermatitis (eczema) [Insufficient Evidence]
  • bipolar disorder [Insufficient Evidence]
  • cancer [Insufficient Evidence]
  • candidiasis, oropharyngeal [Insufficient Evidence]
  • C. difficile infection [Insufficient Evidence]
  • child development [Insufficient Evidence]
  • colic [Possibly Effective]
  • constipation [Possibly Effective]
  • critical illness (trauma) [Insufficient Evidence]
  • dental caries [Possibly Ineffective]
  • dental plaque [Insufficient Evidence]
  • diabetes [Insufficient Evidence]
  • diarrhea [Insufficient Evidence]
  • diarrhea, antibiotic-associated [Insufficient Evidence]
  • diarrhea, malnourishment-related [Insufficient Evidence]
  • diarrhea, radiation-related [Insufficient Evidence]
  • diarrhea, rotaviral [Insufficient Evidence]
  • familial hypercholesterolemia [Insufficient Evidence]
  • generalized anxiety disorder [Insufficient Evidence]
  • gingivitis [Insufficient Evidence]
  • H. pylori infection [Insufficient Evidence]
  • hypercholesterolemia [Insufficient Evidence]
  • IBS [Possibly Effective]
  • inflammatory bowel disease [Insufficient Evidence]
  • malnutrition [Insufficient Evidence]
  • metabolic syndrome [Insufficient Evidence]
  • nausea/vomiting, pregnancy-induced [Insufficient Evidence]
  • necrotizing enterocolitis [Insufficient Evidence]
  • neonatal jaundice [Insufficient Evidence]
  • metabolic dysfunction-associated steatotic liver disease [Insufficient Evidence]
  • obesity [Insufficient Evidence]
  • otitis media [Insufficient Evidence]
  • periodontitis [Insufficient Evidence]
  • postop bowel function [Insufficient Evidence]
  • postpartum depression [Insufficient Evidence]
  • Prader-Willi syndrome [Insufficient Evidence]
  • prematurity [Insufficient Evidence]
  • psoriasis [Insufficient Evidence]
  • respiratory infections [Possibly Effective]
  • rheumatoid arthritis [Insufficient Evidence]
  • ulcerative colitis [Insufficient Evidence]
  • UTI [Insufficient Evidence]
  • ventilator-associated pneumonia prevention [Insufficient Evidence]

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form